Aclarion (ACON) director awarded 20,000 RSUs vesting in 2027

Rhea-AI Filing Summary

Wesemann William reported acquisition or exercise transactions in this Form 4 filing.

Aclarion, Inc. director William Wesemann received an equity award of 20,000 restricted stock units. The RSUs were granted on 6/11/2026 under the company’s equity incentive plan and each unit represents one share of ACON common stock. All RSUs are scheduled to vest on 6/1/2027, with any unvested units fully vesting if a change of control occurs. Following this grant, Wesemann directly holds 21,563 shares of common stock.

Insights

Equity Compensation Analyst

Director received time-based RSU grant that vests in 2027, a routine equity award.

The filing shows William Wesemann, a director of Aclarion, Inc., receiving 20,000 restricted stock units as compensation under the equity incentive plan. The grant price is effectively zero, reflecting a typical stock-based award rather than a market purchase.

All RSUs vest on 6/1/2027, with accelerated vesting upon a change of control as defined in the plan. After the grant, Wesemann holds 21,563 common shares directly. This looks like standard board compensation and does not, by itself, materially change the broader investment thesis.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wesemann William

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	20,000	$0.00	--

Holdings After Transaction: Common Stock — 21,563 shares (Direct, null)

Footnotes (1)

1. The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan. Each RSU represents a contingent right to receive one share of ACON common stock. 100% of the RSUs shall vest on 6/1/2027. Any outstanding and unvested RSUs will also accelerate and fully vest upon a change of control (as defined in the Company's equity incentive plan).

Key Figures

RSU grant size: 20,000 RSUs Grant price per share: $0.00 per share Vesting date: 6/1/2027 +1 more

4 metrics

RSU grant size 20,000 RSUs Granted 6/11/2026 under equity incentive plan

Grant price per share $0.00 per share RSU award, non-cash compensation

Vesting date 6/1/2027 100% of RSUs vest on this date

Shares held after transaction 21,563 shares Total direct Aclarion common stock holdings

Key Terms

restricted stock units ("RSUs"), equity incentive plan, change of control, grant, award, or other acquisition

4 terms

restricted stock units ("RSUs") financial

"The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

equity incentive plan financial

"The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

change of control financial

"Any outstanding and unvested RSUs will also accelerate and fully vest upon a change of control (as defined in the Company's equity incentive plan)."

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wesemann William

(Last) (First) (Middle)

C/O ACLARION, INC.

8181 ARISTA PLACE, SUITE 100

(Street)

BROOMFIELD COLORADO 80021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aclarion, Inc. [ ACON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A		20,000(1)(2)	A	$0.00	21,563	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan. Each RSU represents a contingent right to receive one share of ACON common stock.

2. 100% of the RSUs shall vest on 6/1/2027. Any outstanding and unvested RSUs will also accelerate and fully vest upon a change of control (as defined in the Company's equity incentive plan).

	/s/ William Wesemann	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Aclarion (ACON) report for William Wesemann?

Aclarion reported that director William Wesemann received 20,000 restricted stock units as an equity award. The grant was made on June 11, 2026 and reflects compensation under the company’s equity incentive plan, not an open-market share purchase or sale.

How many Aclarion (ACON) shares does William Wesemann hold after this Form 4 filing?

After the reported RSU grant, William Wesemann directly holds 21,563 shares of Aclarion common stock. This total includes the impact of the 20,000 restricted stock units granted as part of his director compensation under the company’s equity incentive plan.

When do William Wesemann’s Aclarion (ACON) RSUs vest?

All of William Wesemann’s 20,000 Aclarion restricted stock units are scheduled to vest on June 1, 2027. The filing also states that any outstanding and unvested RSUs will fully vest if a change of control occurs, as defined in the equity incentive plan.

Are the Aclarion (ACON) RSUs granted to William Wesemann linked to a change of control?

Yes. The filing explains that any outstanding and unvested restricted stock units granted to William Wesemann will accelerate and fully vest upon a change of control. The term “change of control” follows the definition contained in Aclarion’s equity incentive plan.

Did William Wesemann buy or sell Aclarion (ACON) shares on the open market?

No open-market trades are reported in this Form 4. The transaction is coded as a grant or award acquisition of 20,000 restricted stock units at a price of $0.00 per share, reflecting stock-based compensation rather than a discretionary market purchase or sale.